Crinetics Pharmaceuticals Inc buy SVB Leerink LLC
Start price
29.09.25
/
50%
€38.40
Target price
29.09.26
€75.07
Performance (%)
25.52%
Price
16.01.26
€48.20
Summary
This prediction is currently active. The prediction currently has a performance of 25.52%. This prediction currently runs until 29.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 5.240% | 5.240% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Leerink Partners from $80.00 to $88.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat